CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 76 enrolled
Drug / intervention
Revitive IX Neuromuscular Stimulation Devicedevice
Likely dose
Revitive IX neuromuscular stimulation device with 30-minute pre-programmed varying electrical stimulation sequenceAI-extracted
Key inclusion· 5
  • Diagnosis of chronic venous insufficiency classified as C3-C5 on CEAP scale
  • Age 18 years or older
  • Blood pressure currently under moderate control
  • No current foot ulceration
Key exclusion· 7
  • Pregnant
  • Has cardiac pacemaker, AICD, or other implanted electrical device
  • Existing deep vein thrombosis (DVT)
  • Recent lower limb injury or lower back pain

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03850496
NCT03850496N/ACompleted

Dosing of Electrical Stimulation in Venous Insufficiency

Imperial College London·interventional·Posted Feb 21, 2019·Updated Jul 31, 2020

In Brief

A clinical study evaluating Revitive IX Neuromuscular Stimulation Device for Varicose Veins and 2 related conditions. Completed, enrolled 76 participants.

Detailed Summary

This study is designed to describe the difference in varicose vein outcomes found from using a neuromuscular electrical stimulation device for different amounts of time - Group A (control - no device), Group B (device for 30 mins per day) and Group C (device for 60 mins per day). The groups are assessed after 6 weeks of intervention.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
Countries--
CollaboratorsActegy Ltd.

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedFeb 21, 2019
Enrollment StartNov 1, 2015
Primary CompletionAug 31, 2016
Study CompletionOct 31, 2016
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 7.4 years ago

Interventions

Revitive IX Neuromuscular Stimulation Devicedevice

Neuromuscular stimulation footplate device with a pre-programmed 30 minute varying electrical stimulation sequence.